Janumet XR CP
Generic: Sitagliptin/Metforminby MSD Pharmaceuticals Pvt. Ltd.

Select pack size
Similar medicines
View allAbout Janumet XR CP
Janumet XR CP is an MSD India "combipack" for type 2 diabetes. It is not one combined tablet. Each day of the strip holds two separate tablets: one sitagliptin 100 mg film-coated tablet and one metformin hydrochloride 1000 mg sustained-release tablet. The strip in our product photo is titled "Sitagliptin Phosphate Tablets IP & Metformin Hydrochloride SR Tablets IP Combipack" and says each strip contains "7 tablets each of (A) and (B)", marked Day 1 to Day 7. Our packs are listed as 28, 56 and 84 tablets. Each day takes two tablets, so we read that as 14, 28 and 42 days of treatment (2, 4 and 6 strips), about $2.14 to $2.43 a day before shipping (our arithmetic on that reading; see Price per day for how to check).
Three points before you read further. First, this Indian pack is different from the Janumet XR sold in the US, Canada and Australia, which is a single tablet that contains both medicines; the daily doses (sitagliptin 100 mg and metformin 1000 mg extended release) are the same as the US Janumet XR 100 mg/1000 mg tablet. Second, the 100 mg of sitagliptin in each day's pair is the full daily maximum, so this pack is not suitable for anyone whose kidney function (eGFR) is below 45, and you must never take two days' tablets together. Third, it needs a doctor: kidney tests before you start and at least once a year, and blood glucose and HbA1c checks. This page uses the current US Janumet XR and Januvia labels, the UK Janumet product information and Indian pharmacy listings, all listed at the end.
Janumet XR CP at a glance
| Active ingredients | Sitagliptin 100 mg (as sitagliptin phosphate monohydrate) in one tablet, and metformin hydrochloride 1000 mg sustained release in a second tablet, taken as a daily pair (strip in our product photo; Truemeds and Netmeds call it a combipack) |
| Brand and maker | Janumet XR CP, MSD Pharmaceuticals Pvt Ltd (India). The strip in our product photo says "Combipack manufactured by: MSD Pharmaceuticals Pvt. Ltd." at Strides Pharma Science Limited, Puducherry |
| Drug classes | DPP-4 inhibitor (sitagliptin) and biguanide (metformin) |
| Regulatory status | Sitagliptin with extended-release metformin is licensed as Janumet XR in the US (FDA, 2012), Canada and Australia, with generic versions in the US and Canada. We found no extended-release sitagliptin and metformin tablet on the UK emc, only the twice daily Janumet tablet. This Indian combipack is not registered with the FDA, MHRA, TGA or Health Canada |
| Usual dose from the label | US Janumet XR label: once daily with a meal; maximum 100 mg sitagliptin and 2000 mg extended-release metformin a day. One Janumet XR CP pair (100 mg plus 1000 mg) matches the label's starting dose for people not already taking metformin |
| Half-life | Sitagliptin: apparent terminal half-life about 12.4 hours after a single 100 mg dose (US label section 12.3) |
| Packs | Listed as 28, 56 and 84 tablets. Each Indian strip holds 14 tablets (7 days), so we read these as 2, 4 and 6 strips, or 14, 28 and 42 days (our reading; see Price per day) |
| Price per day | About $2.14 to $2.43 a day before shipping; $2.74 to $4.21 with shipping (our arithmetic, at two tablets a day) |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
What is in the strip
- Tablet A, sitagliptin 100 mg: a small round film-coated tablet. The strip says each film-coated tablet contains sitagliptin phosphate monohydrate IP equivalent to 100 mg of sitagliptin, coloured with iron oxide yellow, iron oxide red and titanium dioxide.
- Tablet B, metformin 1000 mg SR: a large oblong tablet. The strip says each uncoated tablet contains 1000 mg of metformin hydrochloride IP in a sustained-release form, and: "Do not break, crush, or chew before swallowing".
- Layout: seven of each, in day-marked pockets (Day 1 to Day 7), so one strip is one week of treatment.
- Other strip text: "For Oral use", "Store below 30°C", "Store Protected From Moisture", "Dosage: As directed by the physician", "For Sale in India only - Not for Export", and a prescription-only caution.
Indian listings count the same strip in different ways: Apollo Pharmacy calls it "1's (7+7 Tablet)", Truemeds a strip of 14 units, Netmeds and Medkart "7's", and PharmEasy has one listing as a strip of 7 tablets and another as a strip of 14 tablets at the same MRP. Tata 1mg lists the composition only as "Sitagliptin + Metformin (100mg)".
How we count our packs. Our packs are listed as "28 Tablet/s", "56 Tablet/s" and "84 Tablet/s", the same way we list single-tablet medicines such as Januvia, so this page assumes they count tablets: a 28 pack is two strips (14 days), a 56 pack four strips (28 days) and an 84 pack six strips (42 days). This is our reading, not something the strip states. Before you order, ask us to confirm how many strips you will receive, and count the strips when the parcel arrives: each strip has Day 1 to Day 7 pockets and holds 14 tablets.
Price per day
Prices below are as of October 2026; the pack selector shows the current price. Per-day figures are our arithmetic, assuming the pack sizes count tablets and you take two tablets (one pair) a day.
| Pack | Price | Per day (2 tablets) | Shipping | Per day with shipping |
|---|---|---|---|---|
| 28 tablets (2 strips, 14 days) | $34 | $2.43 | $25 | $4.21 |
| 56 tablets (4 strips, 28 days) | $64 | $2.29 | $25 | $3.18 |
| 84 tablets (6 strips, 42 days) | $90 | $2.14 | $25 | $2.74 |
The larger packs cost a little less per day before shipping as well, and the $25 shipping charge is spread over more days. Free shipping starts at $149; the cheapest way to reach it is an 84 pack plus a 56 pack ($154), which is 140 tablets, or 70 days at one pair a day (our arithmetic). Diabetes treatment and kidney function can change, so do not buy more than your doctor expects you to need, and check the expiry dates on the strips.
How long a pack lasts: at one pair (two tablets) a day, a 28 pack lasts 14 days, a 56 pack 28 days and an 84 pack 42 days (our arithmetic, on the tablet-count reading above). Delivery takes 7 to 14 business days, so order well before your current supply ends, and check the expiry date on the strips when they arrive.
Compared with Janumet XR and US generics
| Janumet XR CP (ours) | Janumet XR 100 mg/1000 mg (US) | US generic sitagliptin and metformin ER 100 mg/1000 mg | US generic sitagliptin 100 mg plus generic metformin ER (2 x 500 mg) | |
|---|---|---|---|---|
| What you take each day | Two tablets (one of each) | One tablet | One tablet | Three tablets |
| Maker | MSD (India) | Merck Sharp & Dohme | For example Par | Several US generic makers |
| FDA approved | No | Yes | Yes | Yes, each as a single-ingredient tablet |
| Cost per day | $2.14 to $2.43 before shipping, $2.74 to $4.21 with shipping (our arithmetic) | About $10.55 (NADAC $10.55406) | About $8.34 (NADAC $8.34261) | About $3.91 (NADAC $3.84929 plus 2 x $0.02841) |
NADAC is the average price US pharmacies pay to buy a medicine, published by the US Medicaid programme; it is not the price a patient pays at the counter, and insurance can change what you pay a great deal. The figures are per-tablet rows effective 21 October 2026: Janumet XR 100-1,000 mg ($10.55406), generic sitagliptin phosphate and metformin ER 100 mg-1,000 mg ($8.34261), Zydus's Zituvimet XR 100-1,000 mg ($10.07802), generic sitagliptin phosphate 100 mg ($3.84929) and generic metformin HCl ER 500 mg ($0.02841). On these figures (our arithmetic), our packs cost less per day than all three US options before shipping. With the $25 shipping charge, the 56 and 84 packs ($3.18 and $2.74 a day) still cost less than separate US generic tablets at NADAC ($3.91 a day), but the 28 pack ($4.21 a day) costs more. The cheapest US route is separate generic sitagliptin and generic metformin tablets. If you are in the US and have a prescription and insurance, check your copay before you compare.
Separate tablets and the single tablet are not automatically interchangeable. The US Janumet XR label says no efficacy studies were done with Janumet XR itself, and that bioequivalence of Janumet XR tablets "with coadministered sitagliptin and extended-release metformin tablets has been demonstrated for all tablet strengths". That bioequivalence work used US products. We have seen no study comparing the Indian metformin SR tablet in this combipack with US extended-release metformin. Any switch between products is a decision for your doctor, with closer glucose checks afterwards.
Which strength to choose
| Product | Sitagliptin | Metformin | How it fits the labels |
|---|---|---|---|
| Janumet XR CP | 100 mg, once daily | 1000 mg sustained release, once daily | US Janumet XR label: 100 mg/1000 mg once daily is the recommended starting dose for people not already on metformin. Not suitable at an eGFR below 45 (sitagliptin limit 50 mg) |
| Janumet 50mg/500mg | 50 mg, twice daily | 500 mg immediate release, twice daily | US Janumet label: the starting dose for people not already on metformin is 50 mg/500 mg twice daily with meals |
| Janumet 50mg/1000mg | 50 mg, twice daily | 1000 mg immediate release, twice daily | US Janumet label: for people taking metformin 850 mg twice daily; two tablets a day reach the maximum of 100 mg sitagliptin and 2000 mg metformin |
| Januvia 100mg | 100 mg, once daily | None | Sitagliptin alone, for example when metformin is not suitable |
Never take two days' tablets together. The US label sets a maximum of 100 mg sitagliptin a day, which is one tablet A. A second pair would double the sitagliptin to 200 mg. If you need more metformin than 1000 mg a day, the US Janumet XR label says the starting dose for people on metformin should give 100 mg sitagliptin "and the previously prescribed dose of metformin", and for people on immediate-release metformin 850 mg or 1000 mg twice daily it recommends two 50 mg/1000 mg Janumet XR tablets once daily (100 mg sitagliptin with 2000 mg metformin). This combipack cannot give that: it holds only 1000 mg of metformin a day. If you take 1700 mg or 2000 mg of metformin a day now, switching to this pack alone would cut your metformin roughly in half (our arithmetic); only your doctor can decide what to change.
The UK Janumet label makes a related point in its kidney dosing advice: "If no adequate strength of Janumet is available, individual monocomponents should be used instead of the fixed-dose combination."
How to take Janumet XR CP
- Take it exactly as your doctor prescribes. The strip says "Dosage: As directed by the physician".
- Take one tablet A (sitagliptin) and one tablet B (metformin) from the same day's pocket, together, once a day with your evening meal, unless your doctor says otherwise. This is our reading of the labels: the US Janumet XR Medication Guide says to take it once a day with a meal and "It is better to take JANUMET XR with your evening meal"; the Januvia label says sitagliptin "can be taken with or without food"; and a current US metformin extended-release label gives it once daily with the evening meal.
- Swallow tablet B whole. The strip says "Do not break, crush, or chew before swallowing", and the US Janumet XR label says the same for its tablets.
- If you miss a dose, the US Janumet XR Medication Guide says to take it with food as soon as you remember; if you do not remember until the next dose, skip the missed dose and go back to your regular schedule. "Do not take 2 doses of JANUMET XR at the same time." Apply the same rule to both tablets of the pair.
- Have your kidney function (eGFR) tested before you start and at least once a year; older people need tests more often (US label 5.1 and 5.4).
- Tell any doctor who plans an X-ray or scan with contrast dye, or surgery, that you take metformin (see below).
- The US label says incompletely dissolved Janumet XR tablets may be passed in the stool, and that people who repeatedly see tablets in their stool should tell their doctor, who should check glucose control. We do not know whether the Indian metformin SR tablet does this; if you notice it, tell your doctor.
- Never start, stop, switch or combine diabetes medicines on your own.
Lower doses and extra care for some groups
- Kidney impairment. The US Janumet XR label contraindicates it at an eGFR below 30 mL/min/1.73 m2, says starting it at an eGFR of 30 to 45 "is not recommended", and says that if eGFR later falls below 45 the doctor should assess the benefit and risk of continuing "and limit dose of the sitagliptin component to 50 mg once daily". The Januvia label gives sitagliptin 50 mg once daily at an eGFR of 30 to below 45 and 25 mg below 30. Each Janumet XR CP pair contains 100 mg of sitagliptin, so it is not suitable for anyone with an eGFR below 45. The UK Janumet label sets the maximum sitagliptin dose at 50 mg and the maximum metformin dose at 1000 mg a day at a GFR of 30 to 44 mL/min.
- Older people. The US label says dose selection for an elderly patient "should be cautious, usually starting at the low end of the dosing range", and that kidney function should be checked more often. The UK label says older people may need kidney tests every 3 to 6 months.
- Liver problems. The US label says Janumet XR "is not recommended in patients with hepatic impairment" (8.7) and to avoid it in people with clinical or laboratory evidence of liver disease (5.1). The UK Janumet label says it "must not be used in patients with hepatic impairment" and lists hepatic impairment as a contraindication.
- People at risk of heart failure. See the heart failure section below.
- People on a sulfonylurea or insulin. The US label says a lower dose of the sulfonylurea or insulin may be needed to reduce the risk of low blood sugar (5.6).
- Children. The US label says safety and effectiveness have not been established in children. The UK Janumet label says it "should not be used in children and adolescents 10 to 17 years of age because of insufficient efficacy".
Lactic acidosis (boxed warning)
The US Janumet XR label carries a boxed warning for lactic acidosis caused by metformin, a rare build-up of acid in the blood. In the label's words: "Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin-associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain."
The boxed warning lists these risk factors: "renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic impairment, and mitochondrial diseases." It ends: "If metformin-associated lactic acidosis is suspected, immediately discontinue JANUMET XR and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended." The UK Janumet label adds inadequately controlled diabetes, ketosis and prolonged fasting, and says that if you become dehydrated (severe vomiting, diarrhoea, fever or reduced fluid intake), metformin "should be temporarily discontinued and contact with a health care professional is recommended".
Symptoms (US Medication Guide): feeling cold in your hands or feet, feeling dizzy or lightheaded, a slow or irregular heartbeat, feeling very weak or tired, unusual muscle pain, trouble breathing, feeling sleepy or drowsy, and stomach pains, nausea or vomiting. The Medication Guide says lactic acidosis "is a medical emergency and must be treated in the hospital", and to stop taking the tablets and call your doctor right away. The UK Janumet label says "the patient should stop taking metformin and seek immediate medical attention".
Contrast dye and surgery. The US label says to stop the tablets at the time of, or before, an iodinated contrast imaging procedure in people with an eGFR of 30 to 60, a history of liver disease, alcoholism or heart failure, or when contrast is given into an artery, then recheck eGFR 48 hours later and restart if kidney function is stable (2.3). It also says to stop them for a while when food and fluids are restricted for surgery or other procedures (5.1). The UK Janumet label says to stop before or at the time of intravascular iodinated contrast (dye injected into a blood vessel) and not restart until at least 48 hours after, once kidney function has been rechecked and found stable, and to stop at the time of surgery under general, spinal or epidural anaesthesia, restarting no earlier than 48 hours after surgery or after eating again.
Pancreatitis
The US label says there have been postmarketing reports of acute pancreatitis, "including fatal and non-fatal hemorrhagic or necrotizing pancreatitis", in people taking sitagliptin with or without metformin, and that it is unknown whether people with a history of pancreatitis are at higher risk (5.2). In a pooled analysis of 19 trials (10,246 patients), acute pancreatitis occurred at 0.1 per 100 patient-years in both the sitagliptin and control groups (US 6.1).
Before you start, the US Medication Guide says to tell your doctor if you have ever had pancreatitis, gallstones, a history of alcoholism or high blood triglyceride levels. Stop taking it and call your doctor right away if you have pain in your stomach area "that is severe and will not go away", which may go through to your back, with or without vomiting. The UK Janumet label says that if acute pancreatitis is confirmed, Janumet "should not be restarted", and that caution should be used in people with a history of pancreatitis.
Heart failure
The US label says an association between DPP-4 inhibitor treatment and heart failure "has been observed in cardiovascular outcomes trials for two other members of the DPP-4 inhibitor class" (5.3). It tells doctors to consider the risks and benefits before starting it in people at risk of heart failure, "such as those with a prior history of heart failure and a history of renal impairment", and to watch them for heart failure during treatment.
For sitagliptin itself, the UK Janumet label reports the TECOS trial: 14,671 people with type 2 diabetes and established cardiovascular disease took sitagliptin or placebo on top of usual care for a median of 3 years.
| TECOS outcome | Sitagliptin (7,332) | Placebo (7,339) | Hazard ratio (95% CI) |
|---|---|---|---|
| Cardiovascular death, heart attack, stroke or hospital stay for unstable angina | 839 (11.4%) | 851 (11.6%) | 0.98 (0.89 to 1.08) |
| Hospital admission for heart failure | 228 (3.1%) | 229 (3.1%) | 1.00 (0.83 to 1.20) |
| Death from any cause | 547 (7.5%) | 537 (7.3%) | 1.01 (0.90 to 1.14) |
Selected rows. Source: UK Janumet SmPC section 5.1, Table 3 (intention-to-treat population). The label says sitagliptin "did not increase the risk of major adverse cardiovascular events or the risk of hospitalisation for heart failure" compared with usual care without it. Metformin is a separate issue: the UK Janumet label lists cardiac or respiratory failure, recent heart attack and shock, as conditions that can starve tissues of oxygen, among its contraindications, and the US label lists acute congestive heart failure as a lactic acidosis risk.
Signs of heart failure (US Medication Guide): increasing shortness of breath or trouble breathing, especially when you lie down; swelling or fluid retention, especially in the feet, ankles or legs; an unusually fast increase in weight; and unusual tiredness. Contact your doctor right away if you notice them.
Low blood sugar (hypoglycaemia)
Low blood sugar was uncommon with sitagliptin and metformin alone in the US label's trials, but it became more common when they were combined with a sulfonylurea (such as glimepiride) or insulin. In the US label's trials, symptoms of low blood sugar were reported by 1.6% of people on sitagliptin with immediate-release metformin, against 0.6% on placebo. When sitagliptin was added to metformin and glimepiride for 24 weeks, 16.4% reported low blood sugar, against 0.9% on placebo; added to metformin and insulin, 15.3% against 8.2% (US label 6.1, Table 3).
Signs (US Medication Guide): headache, drowsiness, irritability, hunger, dizziness, confusion, sweating, feeling jittery, weakness and a fast heartbeat. If you take a sulfonylurea or insulin, ask your doctor whether that dose should be lowered, and how to treat a low reading. If someone is unconscious or cannot swallow, call emergency services; as general first aid, do not put food or drink in their mouth.
Side effects
The US Janumet XR label gives no trial of Janumet XR itself, so its side effect figures come from trials of sitagliptin given with immediate-release metformin. In a 24 week placebo-controlled trial in people whose diabetes was not controlled by diet and exercise:
| Effect | Sitagliptin with metformin | Metformin alone | Sitagliptin alone | Placebo |
|---|---|---|---|---|
| Diarrhoea | 7.5% | 7.7% | 2.8% | 4.0% |
| Upper respiratory tract infection | 6.2% | 5.2% | 4.5% | 5.1% |
| Headache | 5.9% | 3.8% | 1.1% | 2.8% |
Source: US Janumet XR label section 6.1, Table 1 (events in 5% or more on the combination and more than on placebo; metformin 500 mg or 1000 mg twice daily). In the same trial, nausea was reported by 4.8% on the combination and vomiting by 2.2% (Table 2). In a separate 24 week trial of extended-release metformin added to glyburide, the most common effects were low blood sugar (13.7% vs 4.9%), diarrhoea (12.5% vs 5.6%) and nausea (6.7% vs 4.2%). The US Medication Guide says that taking the tablets with meals can lessen the stomach side effects of metformin that usually happen at the start of treatment, and that stomach problems that start later "may be a sign of something more serious".
Vitamin B12. In 29 week metformin trials, vitamin B12 fell to below normal in about 7% of patients. The US label advises checking blood counts every year and vitamin B12 every 2 to 3 years (5.5).
Other warnings in the US label: serious allergic reactions (anaphylaxis, angioedema and skin reactions including Stevens-Johnson syndrome), which began within the first 3 months, some after the first dose (5.7); severe and disabling joint pain, which can start from one day to years after starting (5.8); bullous pemphigoid, a blistering skin condition (5.9); and worsening kidney function, including acute kidney failure, sometimes needing dialysis (5.4). Postmarketing reports, without a reliable frequency, also include hepatic enzyme rises, liver injury, constipation, vomiting, headache, muscle and back pain, itching, mouth ulcers and rhabdomyolysis (6.2).
When to get urgent help
Get emergency help, or ask someone to call for you, if you have:
- Signs of lactic acidosis: feeling very weak or tired, unusual muscle pain, trouble breathing, feeling cold in your hands or feet, dizziness, a slow or irregular heartbeat, or stomach pain with nausea or vomiting. Stop the tablets and get medical help straight away.
- Severe stomach pain that will not go away, which may go through to your back, with or without vomiting: possible pancreatitis. Stop the tablets and call your doctor right away.
- Swelling of the face, lips, tongue or throat, trouble breathing or swallowing, hives, a rash, or blistering or peeling skin. The US Medication Guide says to stop the tablets and call your doctor right away or get emergency medical help.
- Low blood sugar that does not improve after taking sugar, comes back, or causes confusion, fits, fainting or loss of consciousness.
- Sudden or worsening breathlessness, especially lying down, or fast swelling of the legs or weight gain: possible heart failure.
- Taking more than your prescribed dose, or a child swallowing the tablets. The US Medication Guide says to call your doctor or local Poison Control Center right away (US 1-800-222-1222, Australia 13 11 26). The US label says lactic acidosis was reported in about 32% of metformin overdose cases.
Tell the emergency staff that you take sitagliptin and metformin (Janumet XR CP), how much and when.
Blisters or skin erosions (US label 5.9) and severe joint pain (5.8) also need prompt medical advice.
Who should not take Janumet XR CP
Never take it if (US Janumet XR label contraindications, unless the UK label is named):
- your eGFR is below 30 mL/min/1.73 m2 (severe kidney impairment). Because of the 100 mg sitagliptin in each pair, this pack is also not suitable at an eGFR below 45 (see above).
- you have acute or chronic metabolic acidosis, including diabetic ketoacidosis
- you have had a serious allergic reaction to Janumet XR, sitagliptin or metformin, such as anaphylaxis or angioedema. The UK label covers allergy to any ingredient of the tablets.
- UK Janumet label contraindications: diabetic pre-coma; acute conditions that can affect the kidneys (dehydration, severe infection, shock, intravascular iodinated contrast); acute or chronic disease which may cause tissue hypoxia, such as cardiac or respiratory failure, recent heart attack or shock; hepatic impairment; acute alcohol intoxication or alcoholism; and breastfeeding
Avoid, not recommended or use only with care:
- Type 1 diabetes: the US label says it "should not be used" in type 1 diabetes, and the UK label says it should not be used in type 1 diabetes and "must not be used for the treatment of diabetic ketoacidosis".
- Starting it at an eGFR of 30 to 45: "not recommended" (US label).
- Liver impairment: "not recommended" (US label); a contraindication in the UK label.
- Known mitochondrial disease such as MELAS or MIDD: "not recommended" (US and UK labels).
- A history of pancreatitis: the US label says it has not been studied in these patients; the UK label says use caution.
- A history of angioedema with another DPP-4 inhibitor: the US label says use caution (5.7).
- People at risk of heart failure: weigh the risks and benefits first (US 5.3).
- Alcohol: the US label warns against excessive alcohol intake (5.1), and its interaction table says to "Warn patients against alcohol intake" (7).
Pregnancy and breastfeeding. The UK Janumet label says it "should not be used during pregnancy", and that if a patient wishes to become pregnant or becomes pregnant, treatment should be stopped and the patient switched to insulin as soon as possible; it lists breastfeeding as a contraindication. The US Janumet XR label says the limited data in pregnant women are not enough to show a drug-associated risk, that poorly controlled diabetes in pregnancy carries risks for mother and baby, and that for breastfeeding the benefits should be weighed against the mother's need for the medicine and possible effects on the infant. The US label also says metformin may cause ovulation in some women who do not ovulate, which can lead to an unplanned pregnancy. Talk to your doctor before a pregnancy.
Medicines that interact
- Sulfonylureas and insulin: more low blood sugar; a lower dose of the sulfonylurea or insulin may be needed (US 5.6, 7).
- Carbonic anhydrase inhibitors (topiramate, zonisamide, acetazolamide, dichlorphenamide): may raise the lactic acidosis risk; the US label advises more frequent monitoring.
- Medicines that reduce metformin clearance, such as ranolazine, vandetanib, dolutegravir and cimetidine: can raise metformin levels; the US label says to consider the benefits and risks of using them together.
- Medicines that can raise blood sugar (US label): thiazide and other diuretics, corticosteroids, phenothiazines, thyroid medicines, oestrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers and isoniazid. Watch for loss of control when one is started and for low blood sugar when one is stopped.
- Medicines that can affect the kidneys, such as NSAIDs (including COX-2 inhibitors), ACE inhibitors, angiotensin II receptor blockers and diuretics, especially loop diuretics: the UK Janumet label says close monitoring of kidney function is needed.
- Digoxin: the UK label says sitagliptin raised digoxin exposure (AUC) by about 11%, and that people at risk of digoxin toxicity should be monitored.
- Alcohol: it strengthens metformin's effect on lactate (US label Table 4).
Tell your doctor or pharmacist about every medicine and supplement you take before you start, and before you start anything new.
Prescription and legal status
In India, the strip in our product photo carries an Rx mark and a caution that it is not to be sold by retail without the prescription of a registered medical practitioner, and Tata 1mg and Truemeds mark Janumet XR CP as prescription required. India's regulator (DCG(I)) approved sitagliptin with metformin film-coated tablets (50 mg plus 500 mg or 1000 mg) on 28 April 2008, and approved this combipack (a strip of sitagliptin 100 mg film-coated tablets with metformin hydrochloride 1000 mg sustained-release tablets) as an additional strength on 4 June 2014. A single film-coated tablet of sitagliptin with sustained-release metformin (50 mg plus 500 mg, 50 mg plus 1000 mg and 100 mg plus 1000 mg) followed as an additional strength on 24 March 2022.
In the US, Janumet XR (NDA 202270, approved 2 February 2012) and generic sitagliptin and metformin extended-release tablets are prescription medicines, and the FDA says personal importation of unapproved medicines is illegal in most circumstances. In Canada, Janumet XR and generic sitagliptin and metformin XR tablets (Apotex, Sandoz) are marketed as prescription medicines (Health Canada Drug Product Database). In Australia, Janumet XR 100 mg/1000 mg is a Schedule 4 Prescription Only Medicine listed on the PBS (healthdirect). In the UK, Janumet (immediate release, twice daily) is a prescription only medicine (emc), and generic sitagliptin with metformin tablets are also listed on emc; we found no extended-release sitagliptin and metformin tablet on the UK emc, which is not the full MHRA register. Janumet XR CP itself is not registered with the FDA, the MHRA, the TGA or Health Canada. Check the rules where you live.
Buying genuine Janumet XR CP
The MHRA warns that "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have", and it advises UK buyers to "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". That warning covers Janumet XR CP, which is not authorised in the UK. When your order arrives, read the strip: it should say Janumet XR CP, list sitagliptin 100 mg (tablet A) and metformin hydrochloride 1000 mg SR (tablet B), show seven of each in Day 1 to Day 7 pockets, name MSD Pharmaceuticals Pvt Ltd, and carry a batch number and an expiry date. These checks cannot prove that tablets are genuine, because counterfeiters copy packaging. Check your blood glucose closely during the first weeks on any new supply, and tell your doctor if your readings change. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.
Delivery
We ship Janumet XR CP to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries. Shipping costs a flat $25 on orders under $149 and is free from $149. The strip says to store below 30°C and protected from moisture; keep the tablets in the strip until you take them. Diabetes tablets should not run out: order well before your current supply ends, and do not stop or ration your tablets while you wait. See our shipping page and refund policy.
Related guides
- Januvia vs Tradjenta: sitagliptin and linagliptin compared, including kidney dosing and 2026 prices
- Metformin dosage guide: starting doses, titration steps and maximum daily limits
- Metformin side effects: trial incidence rates, GI timing and B12 monitoring
- Metformin vs glimepiride: how the two most prescribed oral diabetes tablets differ
Other forms: Janumet 50mg/500mg, Janumet 50mg/1000mg and Januvia 100mg.
Sources
- Janumet XR (sitagliptin and metformin HCl extended-release) tablets, US prescribing information and Medication Guide, Merck Sharp & Dohme LLC, revised 8/2026 (DailyMed setid 64beb3d2-3aeb-4cd5-ba11-dacf6c9a5b50, SPL version 44, effective 11 August 2026): boxed warning, sections 1, 2.1 to 2.3, 3, 4, 5.1 to 5.9, 6.1 (Tables 1 to 3), 6.2, 7 (Table 4), 8.1 to 8.7, 10, 11, 12.3, 14, 16, 17. DailyMed
- Janumet (sitagliptin and metformin HCl) tablets, US prescribing information, Merck Sharp & Dohme LLC (DailyMed setid d19c7ed0-ad5c-426e-b2df-722508f97d67, SPL version 61, effective 11 August 2026): section 2.1. DailyMed
- Januvia (sitagliptin) tablets, US prescribing information, Merck Sharp & Dohme LLC (DailyMed setid f85a48d0-0407-4c50-b0fa-7673a160bf01, SPL version 71): sections 2.1, 2.2. DailyMed
- Metformin hydrochloride extended-release tablets, US prescribing information, Granules (DailyMed setid a5980bc8-8de8-c456-e053-2a95a90a792e, SPL version 5): section 2.1. DailyMed
- Janumet 50 mg/1000 mg film-coated tablets, UK SmPC, Merck Sharp & Dohme (UK) Limited, PLGB 53095/0036, revised 14 June 2025: sections 4.1 to 4.6, 4.8, 4.9, 5.1 (TECOS, Table 3), 6.4. emc
- UK electronic medicines compendium, search for sitagliptin and metformin, checked 22 October 2026: Janumet 50 mg/1000 mg and generic 50 mg/850 mg and 50 mg/1000 mg film-coated tablets only. emc
- US Food and Drug Administration, Drugs@FDA: Janumet XR, NDA 202270, original approval 2 February 2012 (openFDA), checked 22 October 2026.
- Health Canada Drug Product Database: Janumet XR (DINs 02416786, 02416794, 02416808), Apo-Sitagliptin/Metformin XR and Sandoz Sitagliptin-Metformin XR, marketed, prescription; checked 22 October 2026. Health Canada
- healthdirect Australia, Janumet XR 100 mg/1000 mg: Schedule 4, PBS listed. healthdirect
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC) 2026, per-NDC rows effective 21 October 2026: Janumet XR 100-1,000 mg $10.55406; sitagliptin phosphate-metformin ER 100 mg-1,000 mg $8.34261; Zituvimet XR 100-1,000 mg $10.07802; sitagliptin phosphate 100 mg $3.84929; metformin HCl ER 500 mg $0.02841. data.medicaid.gov
- Central Drugs Standard Control Organisation. Fixed dose combinations approved by DCG(I) since 1961 to 31 December 2019, item 818 (28.04.08) and item 1183 (04.06.14, the sitagliptin 100 mg and metformin hydrochloride 1000 mg SR combipack); and fixed dose combinations approved from 1 January 2022 to 25 August 2022, item 13 (24.03.2022). CDSCO
- Indian pharmacy listings for Janumet XR CP (Apollo Pharmacy, Truemeds, PharmEasy, Tata 1mg, Netmeds, Medkart), checked 22 October 2026, and the strip in our product photo.
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is for information and is not medical advice. Janumet XR CP is a prescription diabetes medicine. Take it only as prescribed by a doctor who monitors your blood glucose, HbA1c and kidney function, and do not start, stop or switch diabetes medicines without your doctor.
Frequently asked questions
What is Janumet XR CP?
Janumet XR CP is an MSD India combipack for type 2 diabetes. Each day of the strip holds two separate tablets: one sitagliptin 100 mg film-coated tablet and one metformin hydrochloride 1000 mg sustained-release tablet. The strip in our product photo says each strip contains 7 tablets of each, marked Day 1 to Day 7. CP stands for combipack, the word printed on the strip.
Is Janumet XR CP the same as Janumet XR?
No. The Janumet XR sold in the US, Canada and Australia is a single tablet that contains both medicines; Janumet XR CP gives the same daily doses (sitagliptin 100 mg and metformin 1000 mg extended release) as two separate tablets. The US Janumet XR label says the single tablet was shown to be bioequivalent to sitagliptin and extended-release metformin taken together, but that work used US products. We have seen no study comparing the Indian metformin SR tablet with US extended-release metformin, so any switch is a decision for your doctor.
What does Janumet XR CP cost per day?
As of October 2026, our packs are listed as 28 tablets ($34), 56 tablets ($64) and 84 tablets ($90). At two tablets a day, and assuming the pack sizes count tablets, that is 14, 28 and 42 days, or about $2.43, $2.29 and $2.14 a day before shipping (our arithmetic). Shipping is $25 under $149, so with shipping a single pack works out at $4.21, $3.18 or $2.74 a day. US pharmacy acquisition costs (NADAC, 21 October 2026) are about $10.55 a day for Janumet XR 100/1000, $8.34 for the generic extended-release tablet and $3.91 for separate generic sitagliptin and metformin ER tablets; NADAC is not what a patient pays, so check your insurance copay. Ask us to confirm the number of strips before you order; the pack selector shows the current price.
How do I take Janumet XR CP?
Exactly as your doctor prescribes; the strip says "Dosage: As directed by the physician". Our reading of the labels is one tablet of each from the same day's pocket, together, once a day with the evening meal: the US Janumet XR Medication Guide says it is better taken with the evening meal, the Januvia label says sitagliptin can be taken with or without food, and US metformin extended-release labels give it with the evening meal. Swallow the metformin tablet whole; the strip says do not break, crush or chew it. If you miss a dose, take it with food when you remember, but if you do not remember until it is time for your next dose, skip the missed dose, and never take two doses at the same time.
What is the maximum dose of Janumet XR CP?
One pair a day. The US Janumet XR label sets a maximum of 100 mg sitagliptin and 2000 mg extended-release metformin a day, and each pair already contains the full 100 mg of sitagliptin. Taking two pairs would give 200 mg of sitagliptin, twice the labelled maximum. If you need more metformin, that is a decision for your doctor, who may prescribe a different product.
Is Janumet XR CP right for me if I already take metformin?
It depends on your metformin dose. Each pair gives 1000 mg of metformin a day. The US Janumet XR label says people already on metformin should start on 100 mg sitagliptin plus the metformin dose they already take, and recommends two 50 mg/1000 mg Janumet XR tablets once daily for people taking metformin 850 mg or 1000 mg twice daily. If you take more than 1000 mg of metformin a day now, this pack alone would lower your metformin dose. Only your doctor can decide.
How long does a pack of Janumet XR CP last?
Our packs are listed as 28, 56 and 84 tablets. At one pair (two tablets) a day, and assuming the pack sizes count tablets, a 28 pack lasts 14 days (2 strips), a 56 pack 28 days (4 strips) and an 84 pack 42 days (6 strips) (our arithmetic). The strip does not settle this and Indian listings count it both as 7 and as 14, so ask us to confirm the number of strips before you order, and count the strips when they arrive; each strip covers 7 days. Delivery takes 7 to 14 business days, so order well before your current supply runs out and check the expiry date on the strips.
Can I take Janumet XR CP if I have kidney problems?
Only with your doctor, and not at all with severe kidney impairment. The US Janumet XR label contraindicates it at an eGFR below 30, says starting it at 30 to 45 is not recommended, and limits sitagliptin to 50 mg once daily if eGFR falls below 45. Because each pair contains 100 mg of sitagliptin, this pack is not suitable for anyone with an eGFR below 45. Kidney function should be tested before starting and at least once a year, more often in older people.
What are the side effects of Janumet XR CP?
In a 24 week US label trial of sitagliptin with immediate-release metformin, the most common effects were diarrhoea (7.5%), upper respiratory tract infection (6.2%) and headache (5.9%). Metformin can lower vitamin B12 (about 7% in 29 week trials). Serious but less common risks named in the US label are lactic acidosis (boxed warning), pancreatitis, heart failure, serious allergic reactions, kidney problems, severe joint pain and bullous pemphigoid, and low blood sugar when it is taken with a sulfonylurea or insulin. Stop the tablets and get help straight away for signs of lactic acidosis, severe stomach pain that will not go away, or swelling of the face, lips, tongue or throat.
Who should not take Janumet XR CP?
The US Janumet XR label contraindicates it with an eGFR below 30, metabolic acidosis including diabetic ketoacidosis, and a past serious allergic reaction to sitagliptin or metformin. It is not for type 1 diabetes. The UK Janumet label also lists liver impairment, heart or respiratory failure, recent heart attack, shock, severe infection, dehydration, alcoholism and breastfeeding as contraindications, and says it should not be used in pregnancy. This pack is also not suitable at an eGFR below 45, and the US label says it is not recommended with liver impairment or mitochondrial disease.
Do I need a prescription for Janumet XR CP, and how long does delivery take?
Sitagliptin with extended-release metformin is a prescription medicine in the US, Canada and Australia (Schedule 4), Janumet is prescription only in the UK, and the Indian strip carries a prescription-only caution. Janumet XR CP itself is not registered with the FDA, MHRA, TGA or Health Canada, and the FDA says personal importation of unapproved medicines is illegal in most circumstances. Check the rules where you live. We ship in plain packaging with tracking in 7 to 14 business days; shipping is $25 under $149 and free from $149.
Medical References
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Janumet XR CP? Tell other buyers how it went.







